scholarly article | Q13442814 |
P50 | author | Michael E. Scheurer | Q55173168 |
Martial Guillaud | Q63468167 | ||
Karen Adler-Storthz | Q63468468 | ||
Michele Follen | Q69963161 | ||
P2093 | author name string | Andrew G Sikora | |
Indu Varier | |||
Laura M Dillon | |||
Jane R Montealegre | |||
Christina G Bracamontes | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Epidemiologic classification of human papillomavirus types associated with cervical cancer | Q29616213 | ||
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA | Q33848918 | ||
US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines | Q36817074 | ||
The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings | Q37250812 | ||
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women | Q37315939 | ||
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe | Q38023288 | ||
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2014 | Q40678763 | ||
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices | Q41156019 | ||
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q42196803 | ||
Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer | Q43596600 | ||
Human papillomavirus-related cellular changes measured by cytometric analysis of DNA ploidy and chromatin texture | Q43710140 | ||
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty | Q43893716 | ||
A controlled trial of a human papillomavirus type 16 vaccine | Q44366335 | ||
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study | Q45206974 | ||
Human papillomavirus-associated cancers - United States, 2004-2008. | Q45899597 | ||
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
The health care costs of cervical human papillomavirus--related disease. | Q50747240 | ||
Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China). | Q51190520 | ||
Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. | Q54495496 | ||
Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention | Q58023998 | ||
Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States | Q61161006 | ||
Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study | Q81348875 | ||
Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity | Q83408842 | ||
P304 | page(s) | 1-12 | |
P577 | publication date | 2017-09-04 | |
P1433 | published in | Ethnicity and Health | Q15752940 |
P1476 | title | Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes |
Q96770006 | Health disparities in cervical cancer: Prevalence of high-risk HPV and cytologic diagnoses according to race |
Q57155968 | Racial differences in HPV types amongst US women with HIV and cervical precancer |
Q47560655 | Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities. |
Search more.